RESUMO
BACKGROUND: Autism Spectrum Disorders (ASD) have long been conceived as developmental disorder. A growing body of data highlights a role for alterations in the gut in the pathoetiology and/or pathophysiology of ASD. Recent work shows alterations in the gut microbiome to have a significant impact on amygdala development in infancy, suggesting that the alterations in the gut microbiome may act to modulate not only amygdala development but how the amygdala modulates the development of the frontal cortex and other brain regions. METHODS: This article reviews wide bodies of data pertaining to the developmental roles of the maternal and foetal gut and immune systems in the regulation of offspring brain development. RESULTS: A number of processes seem to be important in mediating how genetic, epigenetic and environmental factors interact in early development to regulate such gut-mediated changes in the amygdala, wider brain functioning and inter-area connectivity, including via regulation of microRNA (miR)-451, 14-3-3 proteins, cytochrome P450 (CYP)1B1 and the melatonergic pathways. As well as a decrease in the activity of monoamine oxidase, heightened levels of in miR-451 and CYP1B1, coupled to decreased 14-3-3 act to inhibit the synthesis of N-acetylserotonin and melatonin, contributing to the hyperserotonemia that is often evident in ASD, with consequences for mitochondria functioning and the content of released exosomes. These same factors are likely to play a role in regulating placental changes that underpin the association of ASD with preeclampsia and other perinatal risk factors, including exposure to heavy metals and air pollutants. Such alterations in placental and gut processes act to change the amygdala-driven biological underpinnings of affect-cognitive and affect-sensory interactions in the brain. CONCLUSION: Such a perspective readily incorporates previously disparate bodies of data in ASD, including the role of the mu-opioid receptor, dopamine signaling and dopamine receptors, as well as the changes occurring to oxytocin and taurine levels. This has a number of treatment implications, the most readily applicable being the utilization of sodium butyrate and melatonin.
Assuntos
Tonsila do Cerebelo/crescimento & desenvolvimento , Transtorno do Espectro Autista/fisiopatologia , Exossomos , Microbioma Gastrointestinal , MicroRNAs/genética , Mitocôndrias , Epigênese Genética , Feminino , Humanos , Sistema Imunitário , GravidezRESUMO
BACKGROUND: A diverse array of data has been associated with autism spectrum disorder (ASD), reflecting the complexity of its pathophysiology as well as its heterogeneity. Two important hubs have emerged, the placenta/prenatal period and the postnatal gut, with alterations in mitochondria functioning crucial in both. METHODS: Factors acting to regulate mitochondria functioning in ASD across development are reviewed in this article. RESULTS: Decreased vitamin A, and its retinoic acid metabolites, lead to a decrease in CD38 and associated changes that underpin a wide array of data on the biological underpinnings of ASD, including decreased oxytocin, with relevance both prenatally and in the gut. Decreased sirtuins, poly-ADP ribose polymerase-driven decreases in nicotinamide adenine dinucleotide (NAD+), hyperserotonemia, decreased monoamine oxidase, alterations in 14-3-3 proteins, microRNA alterations, dysregulated aryl hydrocarbon receptor activity, suboptimal mitochondria functioning, and decreases in the melatonergic pathways are intimately linked to this. Many of the above processes may be modulating, or mediated by, alterations in mitochondria functioning. Other bodies of data associated with ASD may also be incorporated within these basic processes, including how ASD risk factors such as maternal obesity and preeclampsia, as well as more general prenatal stressors, modulate the likelihood of offspring ASD. CONCLUSION: Such a mitochondria-focussed integrated model of the pathophysiology of ASD has important preventative and treatment implications.
Assuntos
Transtorno do Espectro Autista/fisiopatologia , Mitocôndrias/patologia , Placenta/fisiopatologia , ADP-Ribosil Ciclase 1 , Feminino , Humanos , Melatonina , Ocitocina , Gravidez , Serotonina , Vitamina A , Deficiência de Vitamina ARESUMO
BACKGROUND: Increased gut permeability (leaky gut) and alterations in gut microbiota are now widely accepted as relevant to the etiology, course and treatment of many neuropsychiatric disorders, including Parkinson disease (PD). Although a wide array of data on the biological underpinnings of PD has not yet been linked to such gut-associated changes, increased gut permeability and dysregulated microbiota alter many pathways germane to PD. METHODS: In this article we review and integrate these wider biological changes in PD, including increased oxidative and nitrosative stress, immune-inflammatory processes, tryptophan catabolites and alterations in serotoninergic and melatoninergic pathways. RESULTS: These wider biological changes in PD are compatible with alterations in gut permeability and changes in gut microbiota. By driving tryptophan down the kynurenine pathway, pro-inflammatory cytokines and chronic stress-driven activation of the hypothalamic-pituitary-adrenal axis decrease the availability of serotonin as a precursor for activation of the melatonergic pathways. CONCLUSION: Decreased local melatonin synthesis in glia, gut, neuronal and immune cells is likely to be important to the etiology, course and management of PD.
Assuntos
Depressão/metabolismo , Microbioma Gastrointestinal , Mucosa Intestinal/metabolismo , Melatonina/metabolismo , Doença de Parkinson/metabolismo , Triptofano/metabolismo , Microbioma Gastrointestinal/imunologia , Humanos , Inflamação/imunologia , Inflamação/metabolismo , Intestinos/microbiologia , Estresse Nitrosativo , Oxirredução , PermeabilidadeRESUMO
Decisions are often driven by a combination of immediate perception and previous experience. In this study, we investigated how these two sources of information are integrated and the neural systems that mediate this process. Specifically, we injected a dopamine type 1 antagonist (D1A; SCH23390) or a dopamine type 2 antagonist (D2A; eticlopride) into the dorsal striatum while macaques performed a task in which their choices were driven by perceptual inference and/or reinforcement of past choices. We found that the D2A affected choices based on previous outcomes. However, there were no effects of the D2A on choices driven by perceptual inference. We found that the D1A did not affect perceptual inference or reinforcement learning. Finally, a Bayesian model applied to the results suggested that the D2A may be increasing noise in the striatal representation of value, perhaps by disrupting the striatal population that normally represents value.
Assuntos
Benzazepinas/farmacologia , Comportamento de Escolha/efeitos dos fármacos , Corpo Estriado/efeitos dos fármacos , Antagonistas de Dopamina/administração & dosagem , Antagonistas de Dopamina/farmacologia , Salicilamidas/farmacologia , Animais , Benzazepinas/administração & dosagem , Comportamento de Escolha/fisiologia , Corpo Estriado/fisiologia , Dopamina , Macaca mulatta , Microinjeções , Modelos Psicológicos , Reforço Psicológico , Salicilamidas/administração & dosagemRESUMO
The role that frontal-striatal circuits play in normal behavior remains unclear. Two of the leading hypotheses suggest that these circuits are important for action selection or reinforcement learning. To examine these hypotheses, we carried out an experiment in which monkeys had to select actions in two different task conditions. In the first (random) condition, actions were selected on the basis of perceptual inference. In the second (fixed) condition, the animals used reinforcement from previous trials to select actions. Examination of neural activity showed that the representation of the selected action was stronger in lateral prefrontal cortex (lPFC), and occurred earlier in the lPFC than it did in the dorsal striatum (dSTR). In contrast to this, the representation of action values, in both the random and fixed conditions, was stronger in the dSTR. Thus, the dSTR contains an enriched representation of action value, but it followed frontal cortex in action selection.
Assuntos
Potenciais de Ação/fisiologia , Percepção de Cores/fisiologia , Corpo Estriado/citologia , Tomada de Decisões/fisiologia , Lobo Frontal/citologia , Neurônios/fisiologia , Análise de Variância , Animais , Viés , Corpo Estriado/fisiologia , Movimentos Oculares , Lobo Frontal/fisiologia , Haplorrinos , Masculino , Modelos Neurológicos , Estimulação Luminosa , Recompensa , Fatores de TempoRESUMO
A growing body of evidence suggests that the midbrain dopamine system plays a key role in reinforcement learning and disruption of the midbrain dopamine system in Parkinson's disease (PD) may lead to deficits on tasks that require learning from feedback. We examined how changes in dopamine levels ("ON" and "OFF" their dopamine medication) affect sequence learning from stochastic positive and negative feedback using Bayesian reinforcement learning models. We found deficits in sequence learning in patients with PD when they were "ON" and "OFF" medication relative to healthy controls, but smaller differences between patients "OFF" and "ON". The deficits were mainly due to decreased learning from positive feedback, although across all participant groups learning was more strongly associated with positive than negative feedback in our task. The learning in our task is likely mediated by the relatively depleted dorsal striatum and not the relatively intact ventral striatum. Therefore, the changes we see in our task may be due to a strong loss of phasic dopamine signals in the dorsal striatum in PD.
RESUMO
We were interested in gaining insight into the functional properties of frontal networks based upon their anatomical inputs. We took a neuroinformatics approach, carrying out maximum likelihood hierarchical cluster analysis on 25 frontal cortical areas based upon their anatomical connections, with 68 input areas representing exterosensory, chemosensory, motor, limbic, and other frontal inputs. The analysis revealed a set of statistically robust clusters. We used these clusters to divide the frontal areas into 5 groups, including ventral-lateral, ventral-medial, dorsal-medial, dorsal-lateral, and caudal-orbital groups. Each of these groups was defined by a unique set of inputs. This organization provides insight into the differential roles of each group of areas and suggests a gradient by which orbital and ventral-medial areas may be responsible for decision-making processes based on emotion and primary reinforcers, and lateral frontal areas are more involved in integrating affective and rational information into a common framework.
Assuntos
Lobo Frontal/anatomia & histologia , Lobo Frontal/fisiologia , Modelos Anatômicos , Modelos Neurológicos , Rede Nervosa/anatomia & histologia , Rede Nervosa/fisiologia , Neuroanatomia/métodos , Animais , Simulação por Computador , Interpretação Estatística de Dados , Macaca , Modelos Estatísticos , Vias Neurais/anatomia & histologia , Vias Neurais/fisiologiaRESUMO
Cervical spondylosis is a common cause of radiculopathy and myelopathy, often treated by discectomy and interbody fusion. However, there has been a recent vogue for the use of artificial disc prostheses to decrease the risk of accelerated degenerative disease at adjacent levels. The short-term results of artificial disc replacements have been encouraging, but the long-term justification for using this new technology hinges on whether the incidence of adjacent segment disease decreases. It will also be necessary to demonstrate that movement at the operated levels is maintained and the incidence of device failure is low. We review the radiological, biomechanical and clinical evidence for adjacent segment disease, and the rationale for using artificial cervical disc replacements. There is presently insufficient evidence to justify the widespread use of artificial disc replacements in the treatment of cervical spondylosis, but neither is there sufficient evidence to criticize their use. Present evidence suggests that adjacent segment disease is partly due to the natural history of spondylotic disease and partly due to cervical fusion. Randomized trials are required to ascertain whether the incidence of adjacent segment disease changes with the use of artificial disc replacements in the long term. Indications for the use of artificial discs are presently unclear, but disc replacements might be recommended for 'young' patients who require an anterior cervical discectomy, with good ranges of neck movements, and an awareness of the satisfactory short-term results, but lack of long-term outcome data, preferably within the limits of a clinical trial.